J.P. Morgan Healthcare Conference Presentation
Strongly focused on core therapy areas
Developing pipeline through organic and business development progress
GSK
Infectious
diseases
Respiratory/
HIV
Oncology
immunology
Arexvy
MenABCWY
Pneumococcal 24-valent
mRNA Seasonal influenza/COVID-19
Shingrix
GSK3943104 (Herpes simplex virus)
GSK4348413 (gonorrhoea)
gepotidacin
Brexafemme
Long-acting and ultra-long-acting
N6LS (bNAb¹)
3rd generation INST12
Capsid inhibitor
depemokimab
camlipixant
Nucala (COPD³)
GSK4532990 (NASH4)
GSK3858279 (osteoarthritis pain)
GSK1070806 (atopic dermatitis)
Jemperli
Ojjaara
Blenrep
cobolimab
CD226 axis
tebipenem
bepirovirsen
Enabled by advanced technology and data platforms
Note: select pipeline programmes shown
1. Broadly neutralising antibody 2. Integrase strand transfer inhibitor 3. Chronic obstructive pulmonary disease 4. Non-alcoholic steatohepatitis
ST
5View entire presentation